Clinical Trials Directory

Trials / Completed

CompletedNCT01306708

Amitriptyline Regarding Nimesulide in Acute Idiopathic Adhesive Capsulitis

Comparative Study Between Amitriptyline Regarding Nimesulide Associated to Nervous Blockade in the Acute Treatment of Idiopathic Adhesive Capsulitis

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Universidade do Sul de Santa Catarina · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The adhesive capsulitis is a disease of the shoulder characterized by pain and limitation of movement amplitude. It is defined as for etiology, having discordant theories that related it to an inflammatory condition or to an algoneurodystrophy process. There is not yet a consensus about the best option of treatment. The non-steroidal anti-inflammatories have analgesic and anti-inflammatory activity, where the mechanism of action is the inhibition of prostaglandin synthesis. The antidepressants have been increasingly used in the control of chronic pain and the major action mechanism to have the analgesic effect seems to be based on inhibition of neurotransmitters reuptake noradrenaline and/or serotonin) in nerve cell endings. Literature studies associate the practice of the nerve suprascapular blockade with anaesthetics to good results of clinical improvement of the pain, however, so far, no clinical studies comparing the efficacy of the non-steroidal antiinflammatories or tricyclic antidepressants to nervous blockage were registered in the acute treatment of adhesive capsulitis.

Conditions

Interventions

TypeNameDescription
DRUGamitriptylineNerve suprascapular blockade with local anaesthetic agent (novabupivacaine 0.25%, 10 ml, once per week) + oral tricyclic antidepressant (amitriptyline 25 mg, twice per day, for 14 days);

Timeline

Start date
2011-02-01
Primary completion
2011-07-01
Completion
2011-12-01
First posted
2011-03-02
Last updated
2012-01-31

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01306708. Inclusion in this directory is not an endorsement.